2022 ICD-10-CM Code D09.3

Carcinoma in situ of thyroid and other endocrine glands

Version 2021

Valid for Submission

ICD-10:D09.3
Short Description:Carcinoma in situ of thyroid and other endocrine glands
Long Description:Carcinoma in situ of thyroid and other endocrine glands

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified sites (D09)

D09.3 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of thyroid and other endocrine glands. The code D09.3 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.

The ICD-10-CM code D09.3 might also be used to specify conditions or terms like carcinoma in situ of adrenal cortex, carcinoma in situ of adrenal gland, carcinoma in situ of adrenal medulla, carcinoma in situ of craniopharyngeal duct, carcinoma in situ of endocrine gland , carcinoma in situ of multiple endocrine glands, etc.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: adrenal ; adrenal capsule ; adrenal cortex ; adrenal gland ; adrenal medulla ; cortex ; cortex adrenal ; etc

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D09.3:


Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Convert D09.3 to ICD-9 Code

The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D09.3 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The code D09.3 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»adrenal
C74.9C79.7D09.3D35.0D44.1D49.7
»adrenal
  »capsule
C74.9C79.7D09.3D35.0D44.1D49.7
»adrenal
  »cortex
C74.0C79.7D09.3D35.0D44.1D49.7
»adrenal
  »gland
C74.9C79.7D09.3D35.0D44.1D49.7
»adrenal
  »medulla
C74.1C79.7D09.3D35.0D44.1D49.7
»cortex
C74.0C79.7D09.3D35.0D44.1D49.7
»cortex
  »adrenal
C74.0C79.7D09.3D35.0D44.1D49.7
»craniobuccal pouch
C75.2C79.89D09.3D35.2D44.3D49.7
»craniopharyngeal (duct) (pouch)
C75.2C79.89D09.3D35.3D44.4D49.7
»endocrine gland NEC
C75.9C79.89D09.3D35.9D44.9D49.7
»endocrine gland NEC
  »pluriglandular
C75.8C79.89D09.3D35.7D44.9D49.7
»fossa (of)
  »pituitary
C75.1C79.89D09.3D35.2D44.3D49.7
»gland, glandular (lymphatic) (system) [See Also: Neoplasm, lymph gland]
C75.9C79.89D09.3D35.9D44.9D49.7
»gland, glandular (lymphatic) (system) [See Also: Neoplasm, lymph gland]
  »endocrine NEC
C75.9C79.89D09.3D35.9D44.9D49.7
»hypophysis
C75.1C79.89D09.3D35.2D44.3D49.7
»intrasellar
C75.1C79.89D09.3D35.2D44.3D49.7
»medulla
C74.1C79.7D09.3D35.0D44.1D49.7
»medulla
  »adrenal
C74.1C79.7D09.3D35.0D44.1D49.7
»parathyroid (gland)
C75.0C79.89D09.3D35.1D44.2D49.7
»pineal (body) (gland)
C75.3C79.89D09.3D35.4D44.5D49.7
»pituitary (body) (fossa) (gland) (lobe)
C75.1C79.89D09.3D35.2D44.3D49.7
»pluriendocrine
C75.8C79.89D09.3D35.7D44.9D49.7
»Rathke's pouch
C75.1C79.89D09.3D35.2D44.3D49.7
»sella turcica
C75.1C79.89D09.3D35.2D44.3D49.7
»suprarenal
C74.9C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »capsule
C74.9C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »cortex
C74.0C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »gland
C74.9C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »medulla
C74.1C79.7D09.3D35.0D44.1D49.7
»thymus (gland)
C37C79.89D09.3D15.0D38.4D49.89
»thyroglossal duct
C73C79.89D09.3D34D44.0D49.7
»thyroid (gland)
C73C79.89D09.3D34D44.0D49.7

Information for Patients


Thyroid Cancer

Your thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It makes hormones that help the body work normally. There are several types of cancer of the thyroid gland. You are at greater risk if you

You should see a doctor if you have a lump or swelling in your neck. Doctors use a physical exam, thyroid tests, other blood and imaging tests, and a biopsy to diagnose thyroid cancer. Treatment depends on the type of cancer you have and how far the cancer has spread. Many patients receive a combination of treatments. They may include surgery, radioactive iodine, hormone treatment, radiation therapy, chemotherapy, or targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Thyroid Cancer—Patient Version Learn about thyroid cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)